![Thomas F. Widmann](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Thomas F. Widmann
Direttore/Membro del Consiglio presso New York Philharmonic
Posizioni attive di Thomas F. Widmann
Società | Posizione | Inizio | Fine |
---|---|---|---|
New York Philharmonic
![]() New York Philharmonic Movies/EntertainmentConsumer Services New York Philharmonic provides live theatrical presentations. The company was founded in 1842 and is headquartered in New York, NY. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Thomas F. Widmann
Precedenti posizioni note di Thomas F. Widmann
Società | Posizione | Inizio | Fine |
---|---|---|---|
CANCER GENETICS, INC. | Direttore/Membro del Consiglio | 27/11/2017 | 31/05/2019 |
Independent Dir/Board Member | 27/11/2017 | 31/05/2019 | |
Immatics Biotechnologies GmbH
![]() Immatics Biotechnologies GmbH Pharmaceuticals: MajorHealth Technology Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany. | Presidente | 01/01/2004 | 12/11/2012 |
Trigen Holdings AG
![]() Trigen Holdings AG Miscellaneous Commercial ServicesCommercial Services Trigen Holdings AG develops drugs focusing on thrombosis and vascular dysfunction. Its product pipeline includes clinical stage candidates, TGN 255, TGN 167 and PR-15. The company has offices in London. Trigen Holdings was founded in 2005 and is headquartered in Martinsried, Germany. | Direttore/Membro del Consiglio | - | 15/12/2009 |
ACTELION | Fondatore | 30/12/1999 | 01/01/2003 |
SYMETIS SA | Direttore/Membro del Consiglio | 11/10/2010 | - |
Wellington Partners GmbH
![]() Wellington Partners GmbH Investment ManagersFinance Wellington Partners GmbH (Wellington Partners) is an independent venture capital firm founded in 1991 by Rolf Christof Dienst. The firm is headquartered in Munich, with offices in Zurich, London, and Palo Alto. | Investitore di Private Equity | 03/01/2003 | - |
Formazione di Thomas F. Widmann
Ruprecht-Karls-Universität Heidelberg | Undergraduate Degree |
University of Geneva | Doctorate Degree |
Statistiche
Distribuzione geografica
Germania | 5 |
Svizzera | 4 |
Stati Uniti | 3 |
Posizioni
Director/Board Member | 4 |
Chairman | 1 |
Undergraduate Degree | 1 |
Settori
Health Technology | 5 |
Consumer Services | 4 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 7 |
---|---|
Trigen Holdings AG
![]() Trigen Holdings AG Miscellaneous Commercial ServicesCommercial Services Trigen Holdings AG develops drugs focusing on thrombosis and vascular dysfunction. Its product pipeline includes clinical stage candidates, TGN 255, TGN 167 and PR-15. The company has offices in London. Trigen Holdings was founded in 2005 and is headquartered in Martinsried, Germany. | Commercial Services |
Immatics Biotechnologies GmbH
![]() Immatics Biotechnologies GmbH Pharmaceuticals: MajorHealth Technology Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany. | Health Technology |
Wellington Partners GmbH
![]() Wellington Partners GmbH Investment ManagersFinance Wellington Partners GmbH (Wellington Partners) is an independent venture capital firm founded in 1991 by Rolf Christof Dienst. The firm is headquartered in Munich, with offices in Zurich, London, and Palo Alto. | Finance |
Actelion Ltd.
![]() Actelion Ltd. Pharmaceuticals: MajorHealth Technology Actelion Ltd. develops, produces and markets pharmaceutical drugs. The firm engages in research, development, manufacturing, and distribution of pharmaceutical, biological, and diagnostic products. The company was founded by Jean-Paul Clozel, Martine Clozel, Walter Fischli, André J. Müller and Thomas Widmann on December 30, 1999 and is headquartered in Allschwil, Switzerland. | Health Technology |
Symetis SA
![]() Symetis SA BiotechnologyHealth Technology Symetis SA develops minimally invasive heart valve replacement devices. Its products include ACURATE TA and ACURATE neo. The company was founded by Simon P. Hoerstrup and Gregor Zünd on September 5, 2001 and is headquartered in Ecublens, Switzerland. | Health Technology |
New York Philharmonic
![]() New York Philharmonic Movies/EntertainmentConsumer Services New York Philharmonic provides live theatrical presentations. The company was founded in 1842 and is headquartered in New York, NY. | Consumer Services |
Cancer Genetics, Inc.
![]() Cancer Genetics, Inc. Medical SpecialtiesHealth Technology Cancer Genetics, Inc. engages in the development, commercialization, and sale of molecular and biomarker-based tests and services. Through its Select One Clinical Trials program, the firm provides a range of clinical trial services for both oncology and non-oncology genetic testing such as bioinformatics, biomarker solutions, bio repository solutions, consulting, cytogenetic testing, nucleic acid extraction and purification, flow cytometry, Focus: NGS Panel, gene expression analyses, genotyping, and pharmacogenomics. The company was founded by Raju S. K. Chaganti on April 8, 1999 and is headquartered in Rutherford, NJ. | Health Technology |
- Borsa valori
- Insiders
- Thomas F. Widmann
- Esperienza